VIDEO: Celebrating a Milestone for Women’s HIV Prevention
July 24, 2020
Today, we are celebrating a milestone: the European Medicines Agency issued a positive scientific opinion for IPM’s monthly dapivirine vaginal ring to reduce HIV risk among women in developing countries. The ring is the first long-acting HIV prevention product, and today’s news opens the door to next steps needed to seek approvals and make the ring available in countries where women’s need is urgent.
Click play above to hear IPM's founder and CEO Zeda Rosenberg describe what today's opinion means for the ring.
This milestone could not have been possible without the hard work and commitment of many partners around the world—researchers, trial communities in Africa, Europe and the United States, civil society, governments, industry, donors, and of course, the women who participated in studies of the ring.
Click play below to watch some of the reactions from our partners!